急性脑梗死初始诊疗方案同时使用CT与MRI/MRA的初步实践
本研究为回顾性观察研究,分析2015年1月至2021年11月由救护车送至本院的急性缺血性卒中患者,2020年4月引入初始治疗方案:所有患者均行CT及MRI/MRA检查,并据此确定rtPA与MT指征。共分析121例,其中63例接受rtPA(常规治疗组18例、方案组45例),98例接受MT(常规治疗组32例、方案组66例)。方案组中位DNT为56.5分钟 vs 常规治疗组97.0分钟(p<0.001),中位DPT为55.0分钟 vs 129.0分钟(p<0.001);DNT≤60分钟比例5.6% vs 69.9%(p<0.001),DPT≤90分钟比例25.0% vs 85.7%(p<0.001)。作者认为该方案显著缩短DNT和DPT。
要点
- 方案组中位DNT 56.5分钟(IQR 41.0-72.0) vs 常规治疗组97.0分钟(IQR 49.0-138.0),p<0.001
- 方案组中位DPT 55.0分钟(IQR 40.5-69.5) vs 常规治疗组129.0分钟(IQR 62.0-196.0),p<0.001
- DNT≤60分钟比例:常规治疗组5.6% vs 方案组69.9%(p<0.001)
- DPT≤90分钟比例:常规治疗组25.0% vs 方案组85.7%(p<0.001)
- 方案要求所有急性缺血性卒中患者完成头颅和胸部CT及MRI/MRA后确定rtPA与MT指征
适用人群与场景
- 2015年1月至2021年11月由救护车送至本院的急性缺血性卒中患者,2020年4月前为常规治疗组,之后为方案组
处置流程与药物剂量
- 2020年4月引入的急性缺血性卒中初始治疗方案:所有患者均行头颅和胸部CT及MRI/MRA检查,并据此确定rtPA与MT的指征
研究设计与关键结果
- 研究类型:回顾性观察研究,分析2015年1月至2021年11月由救护车送至本院的急性缺血性卒中患者,共121例
- 接受rtPA者63例:常规治疗组18例,方案组45例;接受MT者98例:常规治疗组32例,方案组66例
- 中位DNT:常规治疗组97.0分钟(IQR 49.0-138.0) vs 方案组56.5分钟(IQR 41.0-72.0),p<0.001
- 中位DPT:常规治疗组129.0分钟(IQR 62.0-196.0) vs 方案组55.0分钟(IQR 40.5-69.5),p<0.001
- DNT≤60分钟比例:常规治疗组5.6% vs 方案组69.9%,p<0.001
- DPT≤90分钟比例:常规治疗组25.0% vs 方案组85.7%,p<0.001
证据类型、等级与局限
- 证据类型:回顾性观察研究
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,引入包含CT/MRI成像的初始治疗方案可显著缩短DNT和DPT
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Earlier administration of intravenous recombinant tissue-type plasminogen activator (rtPA) and mechanical thrombectomy (MT) improves the neurological prognosis of patients with acute ischemic stroke (AIS). We introduced a new protocol that includes head and chest computed tomography (CT) and magnetic resonance imaging (MRI)/ magnetic resonance angiography (MRA) for all patients, which is quite different from previously evaluated protocols. This study aimed to examine whether this protocol could contribute to the prompt therapeutic intervention of AIS.
METHODS: This is a retrospective observational study analyzing patients with AIS who were transported to our hospital by ambulance between January 2015 and November 2021. An AIS initial treatment protocol was introduced in April 2020, under which, CT and MRI/MRA imaging were performed in all patients, and the indication for rtPA and MT were determined. The participants were divided into those who were treated before and after the protocol introduction (conventional treatment and protocol groups, respectively). The time from hospital arrival to the start of rtPA administration (door-to-needle time: DNT) and the time from hospital arrival to the start of endovascular treatment (door-to-puncture time: DPT) were compared between the groups.
RESULT: A total of 121 patients were analyzed, wherein 63 patients received rtPA (18 in the conventional treatment group and 45 in the protocol group) and 98 patients received MT (32 in the conventional treatment group and 66 in the protocol group). The median DNT was 97.0 (IQR 49.0-138.0) min vs. 56.5 (IQR 41.0-72.0) min (p < 0.001) for the conventional treatment and the protocol groups, respectively. The median DPT was 129.0 (IQR 62.0-196.0) min vs. 55.0 (IQR 40.5-69.5) min (p < 0.001), respectively. Moreover, DNT was achieved within 60 min in 5.6% vs. 69.9% (p < 0.001) and DPT within 90 min in 25.0% vs. 85.7% (p < 0.001), respectively.
CONCLUSION: The introduction of a protocol, including CT/MRI imaging, significantly shortened DNT and DPT.
参考来源
- Kanou S, Nakahara S, Asaki M, et al. Initial medical protocol efforts using both CT and MRI/MRA for acute cerebral infarction. Am J Emerg Med. 2022. PMID: 36183627. doi:10.1016/j.ajem.2022.09.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。